Company Overview of Colony Capital, LLC
Richard D. Nanula
Former Chief Financial Officer, Executive Vice President of Finance and Executive Vice President of Strategy & Communications, Amgen Inc.
|Age||Total Calculated Compensation||This person is connected to 2 Board Members in 2 different organizations across 8 different industries.|
See Board Relationships
2450 BroadwayPhone: 310-282-8820
Santa Monica, California 90404
Board Members Memberships
Former Board Member
Former Chairman of the Board and Chief Executive Officer
Former Independent Director, Member of Audit Committee, Member of Special Programs Committee and Member of Finance Committee
University of California, Santa Barbara
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|Erez Vigodman||Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee|
Teva Pharmaceutical Industries Limited
|Lars Rebien Sørensen||Chief Executive Officer|
Novo Nordisk A/S
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|